Companies

See how salaries can vary from company to company

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. It is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States and Europe; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. The company is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue ... view company details

HedgePath Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for patients with cancers and non-cancerous proliferation disorders in the United States. It primarily focuses on the development of therapies for skin, lung, and prostate cancers. The company's Hedgehog signaling pathway is a primary regulator of cellular processes in vertebrates, including stem cell maintenance, cell differentiation, tissue polarity, and cell proliferation. It also develops super bioavailability (SUBA)-itraconazole oral capsules for patie... view company details

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that is in Phase III clinical trials for the treatment of type 1 and type 2 diabetes; LX9211, which is in Phase Ib clinical development for the treatment of neuropathic pain; and LX276... view company details

Foamix Pharmaceuticals Ltd., a late clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations for dermatological therapy in the United States, France, Denmark, and Germany. Its lead product candidates include FMX101, a novel topical foam formulation of the antibiotic minocycline that has completed third pivotal Phase III clinical trial for the treatment of moderate-to-severe acne; and FMX103, which is in Phase III clinical trial for the treatment of moderate-to-severe papulopustular rosacea. The company's product pipeline includes FCD105 and FMX109 fo... view company details

XOMA Corporation, a biotech company, discovers and develops therapeutic candidates in the United States, Europe, and the Asia Pacific. The company has a pipeline of monoclonal antibodies and technologies to license to pharmaceutical and biotechnology companies to further their clinical development. Its proprietary product candidates include X213, an allosteric inhibitor of prolactin action; XMetA, an insulin receptor-activating antibody to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; IL-2, a therapy for metastatic melanoma and renal cell carcinoma; and PTH1R, an ... view company details

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a clo... view company details

Inpixon, through its subsidiaries, provides big data analytics and location based products and related services for the cyber-security and Internet of things markets worldwide. The company operates in two segments, Indoor Positioning Analytics and Infrastructure. The Indoor Positioning Analytics segment offers various products and services, which are delivered on premise or in the Cloud, as well as hosted Software-as-a-Service based solutions. Its products are based on a technology that detects and locates accessible cellular, Wi-Fi, and Bluetooth devices, as well as uses a data-analytics engi... view company details

Kforce Inc. provides professional staffing services and solutions in the United States and internationally. It operates through Technology (Tech), Finance and Accounting (FA), and Government Solutions (GS) segments. The Tech segment provides temporary staffing and permanent placement services to its clients primarily in the areas of information technology, such as systems/applications architecture and development, project management, enterprise data management, business intelligence, artificial intelligence, machine learning, network architecture, and security. This segment serves clients in v... view company details

Clark College is a public community college in Washington State, serving up to 12,000 students per quarter in highly respected programs including Addiction Counselor Education, Automotive Technology, Computer Science, Culinary (Cuisine and Baking), Data Networking and Cybersecurity, Dental Hygiene, Engineering, Mechatronics, Nursing, Pharmacy Technician, Phlebotomy, and Welding, among others. In addition to our technical programs, Clark offers exceptional academic courses for students completing an associate degree. The college currently offers classes at two satellite locations, on the Washin... view company details

CreativeDrive, now part of Accenture Interactive, is a tech-based, global production services company offering bespoke content solutions at unprecedented speed and one of the largest studio networks in the world. We are comprised of over 1,000 dedicated creators, makers and doers - designers, photographers, directors, engineers, developers and specialists. We combine technology, art and talent to offer custom, scalable solutions to clients while our proprietary platforms and built-in end-to-end technology guarantees transparency, efficiency and data learnings. The CreativeDrive network include... view company details

e2f is a full-service language service provider headquartered in San Jose, California, with presence in Argentina, France, Germany, India, Madagascar, Mauritius, and Vietnam. e2f's expert translators, editors, and project managers provide prompt "follow the sun" 24x5 services. Since its founding in 2003, e2f has offered a broad range of services in translation & localization, multimedia, multilingual staffing and on-device testing. Clients include high tech Silicon Valley firms, global game developers, and a wide range of consumer- and corporate-facing companies. You create it. We globalize it... view company details

Encore Live is driving outcomes through the power of Smart Experience. We are the Dynamic Human Experience Company. Encore Live is a leading integrated event production, talent buying and experiential marketing company founded on the premise that our most deeply held beliefs are those we discover for ourselves through personal experience. We help innovation-minded Brands, Organizations and Creators transform beliefs, relationships and results through events & experiences scaled with tech & data. Every day we make the impossible possible enabled by our own Employee Experience with amazing benef... view company details

FCR has built a new class of high-quality, domestic-based contact center and business process outsourcing solutions. Our mission is to provide innovative support for innovative companies. Headquartered in Eugene, Oregon, with domestic contact center facilities in Oregon and Montana, and international locations in Mexico and Poland, we provide a wide range of call center and business process solutions to industries that include high tech, startups, mobile commerce, wireless, telecom, finance, insurance, e-commerce, healthcare, retail, travel and hospitality, and various sectors of the new econo... view company details

Lineate helps companies go from myth to reality with custom technology. Handling billions of transactions and terabytes of data, our technology solutions have enabled companies like The New York Times, AppNexus, and NYU to achieve their goals for over a decade. Whether we're rolling out a custom CMS that populates over 2,000 websites, providing complex loyalty offers or creating something completely custom, our expertise falls into three main categories: - Building the tech solutions companies need to achieve their goals. - Improving and optimizing the technology companies already have. - Supp... view company details

MedSide was founded in Atlanta, Ga in 1993 to meet the health care needs and to provide the highest quality of home delivered services to the residents of Atlanta. Since 1993, the population of those served has expanded to include the residents of Fulton, Gwinnett, Cobb, and DeKalb counties. In 1999, MedSide became certified to provide home health services including skilled nursing, physical therapy, occupational therapy, speech and language pathology, and medical social services as well as personal care and homemaker support to our clients. In addition, MedSide provides high-tech services suc... view company details

Plugable Technologies is one of the world's best-known brands for USB devices. We created the company from the ground up to focus on better products, better information, and better support than you'll find from any traditional electronics company. With over 120 products and millions of units sold worldwide, Plugable has remained top 5 in the global docking station market. Here at Plugable we believe in making people's lives easier. We do this by listening to our customers needs, simplifying technology and empowering the user. We're proud to have one of the best support teams in the tech indust... view company details

Great Jones is building modern, full-service, highly tech-fueled property management for the several trillion (!) dollars in rental homes owned by small-scale investors. We are live in our first nine markets, raised over $20 million from top investors & entrepreneurs (including our recently closed Series B), and are growing rapidly with nationwide expansion on deck. To sum up the opportunity: it's an enormous addressable market, with highly attractive unit economics, where competition is deeply fragmented and notorious for delivering low-tech, subpar service. Our digital & operational platform... view company details

Akcea Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with serious and rare diseases in the United States and internationally. The company offers TEGSEDI, which is designed to reduce the production of transthyretin protein. It develops WAYLIVRA, which has completed Phase III clinical study for the treatment of familial chylomicronemia syndrome; and that is in Phase III clinical study for the treatment of familial partial lipodystrophy. The company also develops AKCEA-APO(a)-LRx, which has completed Phase IIb clinical study for ... view company details

Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, Iomab-B that is in a pivotal Phase III clinical trial as an induction and conditioning agent in patients over the age of 55 with relapsed or refractory acute myeloid leukemia prior to receiving a bone marrow transplant, also known as a hematopoietic stem cell transplant. The company is also developing Actimab-A, its lead alpha-particle drug cand... view company details

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company is developing small molecule drug candidates primarily engineered to increase muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a novel fast skeletal muscle troponin act... view company details